MIST
Milestone Pharmaceuticals Inc. Common Shares
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$1.87
$-0.10
(-5.08%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $159.27M | EPS (ttm) | $-0.79 | Current Price | $1.87 |
| Enterprise Value | $174.74M | Forward EPS | $-0.60 | Previous Close | $1.97 |
| P/E Ratio | - | ROA | -41.97% | 52W High | $3.06 |
| Forward P/E | -3.13 | ROE | -260.65% | 52W Low | $0.62 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $2.21 |
| P/S Ratio | - | Operating Margin | - | 200 Day Avg | $1.84 |
| P/B Ratio | 9.26 | Profit Margin | - | Volume | 1.80M |
| EV/EBITDA | -3.06 | Current Ratio | 8.23 | Avg Volume | 5.44M |
| EV/Sales | - | Quick Ratio | 7.99 | Beta | 0.46 |
| Employees | 33.00 | Debt/Equity | 279.05 | Shares Outstanding | 85.17M |
| Sector | Healthcare | Total Debt | $57.21M | Float Shares | 77.03M |
| Industry | Biotechnology | Total Cash | $82.58M | Short Float | 11.02% |
| Optionable | Yes | Cash/Share | $0.81 | Short Ratio | 1.14 |
| Dividend Yield | - | Book Value/Share | $0.20 | % Held by Insiders | 3.31% |
| Target Price | $6.60 | Revenue (TTM) | - | % Held by Institutions | 51.04% |